Synthetic biology confronts publics and policy makers: Challenges for communication, regulation and commercialization

Document Type

Article

Department

Office of the Provost

Abstract

The novelty of synthetic biology lies in the use of synthesized parts that can be arranged to make useful products. Such advanced, high-throughput genetic engineering projects redesign and fabricate existing biological systems as well as new biological parts, devices and systems that do not occur in nature. This Opinion discusses challenges raised by synthetic biology for public acceptance, regulation, commercialization and the emerging global issue of access to genetic resources and information. As with all new fields of research, maintaining the trust of the public and policy regulators is paramount. Hype and exaggerated claims are counterproductive to developing adaptive and ethically sound regulatory models responsive to stakeholder concerns.

Comments

This work was published before Tania joined Aga Khan University.

Publication (Name of Journal)

Trends in Biotechnology

DOI

10.1016/j.tibtech.2011.10.003

Link to Full Text

Share

COinS